The SLAS International Conference and Exhibition is the flagship annual conference and exhibition presented by SLAS and the must-attend event dedicated to life sciences discovery and laboratory automation technology.
Schedule
February 7-8: Pre-conference Short Courses and Technology Provider Showcase
February 9-11: Dynamic Exhibition and Eight Scientific Tracks
February 12: NEW! Thrive in Science: SLAS Women's Leadership Forum
Attendance in 2025: 7500+ life sciences researchers and laboratory automation technology professionals under one roof!
Features
Exhibition: SLAS2026 delivers a fast-paced exhibition experience, including opportunities for business-to-business and business-to-consumer interactions. Attendees will see the latest products and services, supplies and suppliers, and have time to investigate automation solutions to drive new discoveries!
Education: Learn from experts across a broad spectrum of academia and industry, sharing their life sciences research and the technological advances that enhance their success. Exhibitor tutorials and case studies, NexusXp: The Connected Lab returns with panel discussions highlighting the DMTA cycle, SLAS Topical Interest Group discussions and more.
Networking: Join discussions and interact with attendees at networking, special interest and social events.
Recognition: SLAS Travel Awards make it possible for podium and poster presenters to earn a free trip to SLAS2026. The SLAS Innovation Award honors the most innovative podium presentation and Student Poster Awards provide new scientists with the opportunity to present their research, receive feedback and possibly win a $500 prize!
SLAS2026 Co-Chairs
David Brierley, Ph.D.
Senior Director, Head of UK Quantitative Biosciences
Merck (MSD), Rahway, NJ
With a career spanning 20 years in both academic and pharmaceutical environments, Brierly works at the interface between assay development, screening and automation technologies. Furthermore, he has actively supported the SLAS organization and community for over a decade, contributing through journal publications, multiple conference track chair roles, and more recently as a member of the Scientific Research Advisory Committee.
Jennifer Smith, Ph.D.
Director
ICCB-Longwood Screening Facility and Drug Discovery Sciences Core
Lecturer, Department of Immunology
Harvard Medical School
Jennifer Smith, Ph.D., is a broadly trained molecular biologist with expertise in virology, assay development, high-throughput screening and data analysis strategies. Jennifer earned her Ph.D. from the University of Minnesota in the Microbiology, Immunology and Cancer Biology Program, where she studied oncolytic reovirus and cellular translational inhibition. She did her postdoctoral research at Harvard Medical School, focusing on oncogenic papillomaviruses. Jen joined the ICCB-L team in 2011. ICCB-Longwood is one of the oldest academic screening cores and has an international reputation for innovative screening technologies and high-impact screens.
SLAS2026 Keynote Speakers
Media Partners
SLAS is pleased to have Zyme Communications as our official Media Coordinator of SLAS2026. Zyme Communications provides strategic and specialist PR and marketing services for the life sciences sector with the goal of building corporate value and generating interest from commercial leads, investors and partners. For more information, contact Katie Odgaard.
